Bevacizumab vs Dacarbazine in Metastatic Melanoma

This study has suspended participant recruitment.
(Lack of financing of the study drug. Not sufficient financial support.)
Sponsor:
Collaborators:
The Norwegian Melanoma Group
Norwegian Cancer Society
Information provided by (Responsible Party):
Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT01705392
First received: October 8, 2012
Last updated: December 19, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)